Please provide your email address to receive an email when new articles are posted on . Alcon intends to acquire Ivantis, the developer and manufacturer of the Hydrus microstent, according to a ...
Please provide your email address to receive an email when new articles are posted on . The first patient has been enrolled in a trial investigating the stand-alone use of the Hydrus microstent in ...
“With more than 85,000 Hydrus devices implanted, now is the time to expand access globally, and Alcon is the right partner as the global leader in eye care,” said Dave Van Meter, President and CEO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results